Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
ABPI releases life sci competition report as UK investment lags
The U.K. is lagging peer countries when it comes to R&D investment, clinical trials and foreign investment, ABPI cautioned in a new report.
Fraiser Kansteiner
Sep 10, 2025 5:30pm
Merck scraps £1B project, along with all R&D operations in UK
Sep 10, 2025 3:40pm
Daiichi, Merck rev up for accelerated approval filing
Sep 7, 2025 10:45am
Merck's oral PCSK9 makes waves with 3rd phase 3 win
Sep 2, 2025 9:35am
Merck axes main asset from $1.9B Pandion buyout
Jul 29, 2025 2:42pm
Sino Biopharm buys Merck’s PD-1xVEGF bispecific partner LaNova
Jul 15, 2025 10:16am
